Manosca, F, Schinstine, M, Fetsch, PA, Sorbara, L, Wilder, AM, Brosky, K, et al. Diagnostic effects of prolonged storage on fresh effusion samples. Diagn Cytopathol. 2007;35:6–11.CrossRefGoogle ScholarPubMed

Moriarty, AT, Schwartz, MR, Ducatman, BS, Booth, CN, Haja, J, Chakraborty, S, et al. A liquid concept – do classic preparations of body cavity fluid perform differently than ThinPrep cases? Observations from the College of American Pathologists Interlaboratory Comparison Program in Nongynecologic Cytology. Arch Pathol Lab Med. 2008;132:1716–18.CrossRefGoogle ScholarPubMed

Hoda, RS. Non-gynecologic cytology on liquid-based preparations: a morphologic review of facts and artifacts. Diagn Cytopathol. 2007;35:621–34.CrossRefGoogle ScholarPubMed

Moriarty, AT, Stastny, J, Volk, EE, Hughes, JH, Miller, TR, Wilbur, DC. Fluids – good and bad actors: observations from the College of American Pathologists Interlaboratory Comparison Program in Nongynecologic Cytology. Arch Pathol Lab Med. 2004;128:513–18.CrossRefGoogle ScholarPubMed

Zhu, H, McMeekin, EM, Sturgis, CD. Desmoplastic small round cell tumor, a “floating island” pattern in pleural fluid cytology: a case report and review of the literature. Case Rep Pathol. 2015;2015:676894.Google ScholarPubMed

Hassan, I, Shyyan, R, Donohue, JH, Edmonson, JH, Gunderson, LL, Moir, CR, et al. Intraabdominal desmoplastic small round cell tumors: a diagnostic and therapeutic challenge. Cancer. 2005;104:1264–70.CrossRefGoogle ScholarPubMed

Abadi, MA, Zakowski, MF. Cytologic features of sarcomas in fluids. Cancer. 1998;84:71–76.3.0.CO;2-G>CrossRefGoogle ScholarPubMed

Husain, AN, Colby, TV, Ordonez, NG, Allen, TC, Attanoos, RL, Beasley, MB, et al. Guidelines for pathologic diagnosis of malignant mesothelioma: 2017 update of the consensus statement from the International Mesothelioma Interest Group. Arch Pathol Lab Med. 2017, Epub ahead of print.CrossRefGoogle Scholar

Hjerpe, A, Ascoli, V, Bedrossian, CW, Boon, ME, Creaney, J, Davidson, B, et al. Guidelines for the cytopathologic diagnosis of epithelioid and mixed-type malignant mesothelioma. Complementary statement from the International Mesothelioma Interest Group, also endorsed by the International Academy of Cytology and the Papanicolaou Society of Cytopathology. Acta Cytol. 2015;59:2–16.CrossRefGoogle ScholarPubMed

Hjerpe, A, Ascoli, V, Bedrossian, CW, Boon, ME, Creaney, J, Davidson, B, et al. Guidelines for the Cytopathologic Diagnosis of Epithelioid and Mixed-Type Malignant Mesothelioma: a secondary publication. Cytopathology. 2015;26:142–56.CrossRefGoogle ScholarPubMed

Hjerpe, A, Ascoli, V, Bedrossian, CW, Boon, ME, Creaney, J, Davidson, B, et al. Guidelines for the cytopathologic diagnosis of epithelioid and mixed-type malignant mesothelioma: Complementary Statement from the International Mesothelioma Interest Group, Also Endorsed by the International Academy of Cytology and the Papanicolaou Society of Cytopathology. Diagn Cytopathol. 2015;43:563–76.CrossRefGoogle ScholarPubMed

Henderson, DW, Reid, G, Kao, SC, Kao, SC, van Zandwijk, N, Klebe, S. Challenges and controversies in the diagnosis of mesothelioma: Part 1. Cytology-only diagnosis, biopsies, immunohistochemistry, discrimination between mesothelioma and reactive mesothelial hyperplasia, and biomarkers. J Clin Pathol. 2013;66:847–53.CrossRefGoogle ScholarPubMed

Paintal, A, Raparia, K, Zakowski, MF, Nayar, R. The diagnosis of malignant mesothelioma in effusion cytology: a reappraisal and results of a multi-institution survey. Cancer Cytopathol. 2013;121:703–07.CrossRefGoogle ScholarPubMed

Rakha, EA, Patil, S, Abdulla, K, Abdulkader, M, Chaudry, Z, Soomro, IN. The sensitivity of cytologic evaluation of pleural fluid in the diagnosis of malignant mesothelioma. Diagn Cytopathol. 2010;38:874–79.CrossRefGoogle ScholarPubMed

Renshaw, AA, Dean, BR, Antman, KH, Antman, KH, Sugarbaker, DJ. The role of cytologic evaluation of pleural fluid in the diagnosis of malignant mesothelioma. Chest. 1997;111:106–09.CrossRefGoogle ScholarPubMed

Bedrossian, CW. An update on pleuro-pulmonary cytopathology: Part I: Cytological diagnosis of mesothelioma and molecular cytology of lung cancer with an historical perspective. Diagn Cytopathol. 2015;43:513–26.CrossRefGoogle ScholarPubMed

Pinelli, V, Laroumagne, S, Sakr, L, Marchetti, GP, Tassi, GF, Astoul, P. Pleural fluid cytological yield and visceral pleural invasion in patients with epithelioid malignant pleural mesothelioma. J Thorac Oncol. 2012;7:595–98.CrossRefGoogle ScholarPubMed

Taliano, RJ, Lu, S, Singh, K, Mangray, S, Tavares, R, Noble, L, et al. Calretinin expression in high-grade invasive ductal carcinoma of the breast is associated with basal-like subtype and unfavorable prognosis. Hum Pathol. 2013;44:2743–50.CrossRefGoogle ScholarPubMed

Duhig, EE, Kalpakos, L, Yang, IA, Clarke, BE. Mesothelial markers in high-grade breast carcinoma. Histopathology. 2011;59:957–64.CrossRefGoogle ScholarPubMed

Hecht, JL, Lee, BH, Pinkus, JL, Pinkus, GS. The value of Wilms tumor susceptibility gene 1 in cytologic preparations as a marker for malignant mesothelioma. Cancer. 2002;96:105–09.CrossRefGoogle ScholarPubMed

Jo, VY, Cibas, ES, Pinkus, GS. Claudin-4 immunohistochemistry is highly effective in distinguishing adenocarcinoma from malignant mesothelioma in effusion cytology. Cancer Cytopathol. 2014;122:299–306.CrossRefGoogle ScholarPubMed

Afshar-Moghaddam, N, Heidarpour, M, Dashti, S. Diagnostic value of claudin-4 marker in pleural and peritoneal effusion cytology: does it differentiate between metastatic adenocarcinoma and reactive mesothelial cells? Adv Biomed Res. 2014;3:161.Google ScholarPubMed

Westfall, DE, Fan, X, Marchevsky, AM. Evidence-based guidelines to optimize the selection of antibody panels in cytopathology: pleural effusions with malignant epithelioid cells. Diagn Cytopathol. 2010;38:9–14.CrossRefGoogle ScholarPubMed

Cakir, E, Demirag, F, Aydin, M, Unsal, E. Cytopathologic differential diagnosis of malignant mesothelioma, adenocarcinoma and reactive mesothelial cells: a logistic regression analysis. Diagn Cytopathol. 2009;37:4–10.CrossRefGoogle ScholarPubMed

Churg, A, Colby, TV, Cagle, P, Corson, J, Gibbs, AR, Gilks, B, et al. The separation of benign and malignant mesothelial proliferations. Am J Surg Pathol. 2000;24:1183–200.Google ScholarPubMed

Hasteh, F, Lin, GY, Weidner, N, Michael, CW. The use of immunohistochemistry to distinguish reactive mesothelial cells from malignant mesothelioma in cytologic effusions. Cancer Cytopathol. 2010;118:90–96.CrossRefGoogle ScholarPubMed

Kuperman, M, Florence, RR, Pantanowitz, L, Visintainer, PF, Cibas, ES, Otis, CN. Distinguishing benign from malignant mesothelial cells in effusions by Glut-1, EMA, and Desmin expression: an evidence-based approach. Diagn Cytopathol. 2013;41:131–40.CrossRefGoogle ScholarPubMed

Hwang, HC, Sheffield, BS, Rodriguez, S, Thompson, K, Tse, CH, Gown, AM, et al. Utility of BAP1 immunohistochemistry and p16 (CDKN2A) FISH in the diagnosis of malignant mesothelioma in effusion cytology specimens. Am J Surg Pathol. 2016;40:120–26.Google ScholarPubMed

Sheffield, BS, Hwang, HC, Lee, AF, Thompson, K, Rodriguez, S, Tse, CH, et al. BAP1 immunohistochemistry and p16 FISH to separate benign from malignant mesothelial proliferations. Am J Surg Pathol. 2015;39:977–82.CrossRefGoogle Scholar

Churg, A, Sheffield, BS, Galateau-Sallé, F. New markers for separating benign from malignant mesothelial proliferations: are we there yet? Arch Pathol Lab Med. 2016;140:318–21.CrossRefGoogle ScholarPubMed

Ito, T, Hamasaki, M, Matsumoto, S, Hiroshima, K, Tsujimura, T, Kawai, T, et al. p16/CDKN2A FISH in differentiation of diffuse malignant peritoneal mesothelioma from mesothelial hyperplasia and epithelial ovarian cancer. Am J Clin Pathol. 2015;143:830–38.CrossRefGoogle ScholarPubMed

Hida, T, Matsumoto, S, Hamasaki, M, Kawahara, K, Tsujimura, T, Hiroshima, K, et al. Deletion status of p16 in effusion smear preparation correlates with that of underlying malignant pleural mesothelioma tissue. Cancer Sci. 2015;106:1635–41.CrossRefGoogle ScholarPubMed

Das, DK, Al-Juwaiser, A, George, SS, Francis, IM, Sathar, SS, Sheikh, ZA, et al. Cytomorphological and immunocytochemical study of non-Hodgkin's lymphoma in pleural effusion and ascitic fluid. Cytopathology. 2007;18:157–67.CrossRefGoogle ScholarPubMed

Bangerter, M, Hildebrand, A, Griesshammer, M. Combined cytomorphologic and immunophenotypic analysis in the diagnostic workup of lymphomatous effusions. Acta Cytol. 2001;45:307–12.CrossRefGoogle ScholarPubMed

Pinzone, MR, Berretta, M, Cacopardo, B, Nunnari, G. Epstein–Barr virus- and Kaposi sarcoma-associated herpesvirus-related malignancies in the setting of human immunodeficiency virus infection. Semin Oncol. 2015;42:258–71.CrossRefGoogle ScholarPubMed

Jones, D, Ballestas, ME, Kaye, KM, Gulizia, JM, Winters, GL, Fletcher, J, et al. Primary-effusion lymphoma and Kaposi's sarcoma in a cardiactransplant recipient. N Engl J Med. 1998;339:444–49.CrossRefGoogle Scholar

Cesarman, E, Nador, RG, Aozasa, K, Delsol, G, Said, JW, Knowles, DM. Kaposi's sarcoma-associated herpesvirus in non-AIDS related lymphomas occurring in body cavities. Am J Pathol. 1996;149:53–57.Google ScholarPubMed

Nador, RG, Cesarman, E, Chadburn, A, Dawson, DB, Ansari, MQ, Said, J, et al. Primary effusion lymphoma: a distinct clinicopathologic entity associated with the Kaposi's sarcoma-associated herpes virus. Blood. 1996;88:645–56.CrossRefGoogle ScholarPubMed

Matolcsy, A, Nádor, RG, Cesarman, E, Knowles, DM. Immunoglobulin VH gene mutational analysis suggests that primary effusion lymphomas derive from different stages of B cell maturation. Am J Pathol. 1998;153:1609–14.CrossRefGoogle ScholarPubMed

Wu, W, Youm, W, Rezk, SA, Zhao, X. Human herpesvirus 8-unrelated primary effusion lymphoma-like lymphoma: report of a rare case and review of 54 cases in the literature. Am J Clin Pathol. 2013;140:258–73.CrossRefGoogle ScholarPubMed

Xiao, J, Selvaggi, SM, Leith, CP, Fitzgerald, SA, Stewart, J 3rd. Kaposi sarcoma herpesvirus/human herpesvirus-8-negative effusion-based lymphoma: report of 3 cases and review of the literature. Cancer Cytopathol. 2013;121:661–69.CrossRefGoogle ScholarPubMed

Klepfish, A, Zuckermann, B, Schattner, A. Primary effusion lymphoma in the absence of HIV infection–clinical presentation and management. Q J Med. 2015;108:481–88.CrossRefGoogle ScholarPubMed